GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CLS Holdings USA Inc (XCNQ:CLSH) » Definitions » Net Margin %

CLS Holdings USA (XCNQ:CLSH) Net Margin % : -7.24% (As of Feb. 2025)


View and export this data going back to 2019. Start your Free Trial

What is CLS Holdings USA Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. CLS Holdings USA's Net Income for the three months ended in Feb. 2025 was C$-0.40 Mil. CLS Holdings USA's Revenue for the three months ended in Feb. 2025 was C$5.51 Mil. Therefore, CLS Holdings USA's net margin for the quarter that ended in Feb. 2025 was -7.24%.

The historical rank and industry rank for CLS Holdings USA's Net Margin % or its related term are showing as below:

XCNQ:CLSH' s Net Margin % Range Over the Past 10 Years
Min: -326.5   Med: -71.01   Max: 2.62
Current: 2.62


XCNQ:CLSH's Net Margin % is ranked worse than
57.39% of 967 companies
in the Drug Manufacturers industry
Industry Median: 4.96 vs XCNQ:CLSH: 2.62

CLS Holdings USA Net Margin % Historical Data

The historical data trend for CLS Holdings USA's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CLS Holdings USA Net Margin % Chart

CLS Holdings USA Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -257.24 -82.37 -10.34 -59.65 -22.48

CLS Holdings USA Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -88.69 34.89 -17.09 -2.12 -7.24

Competitive Comparison of CLS Holdings USA's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CLS Holdings USA's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's Net Margin % distribution charts can be found below:

* The bar in red indicates where CLS Holdings USA's Net Margin % falls into.


;
;

CLS Holdings USA Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

CLS Holdings USA's Net Margin for the fiscal year that ended in May. 2024 is calculated as

Net Margin=Net Income (A: May. 2024 )/Revenue (A: May. 2024 )
=-6.134/27.281
=-22.48 %

CLS Holdings USA's Net Margin for the quarter that ended in Feb. 2025 is calculated as

Net Margin=Net Income (Q: Feb. 2025 )/Revenue (Q: Feb. 2025 )
=-0.399/5.512
=-7.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CLS Holdings USA  (XCNQ:CLSH) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


CLS Holdings USA Net Margin % Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


CLS Holdings USA Business Description

Traded in Other Exchanges
Address
516 South, 4th Street, Las Vegas, NV, USA, 89101
CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.
Executives
Todd Swanson 10% Security Holder